More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$7.15B
EPS
20.87
P/E ratio
25.1
Price to sales
2.52
Dividend yield
0.51%
Beta
0.498904
Previous close
$548.20
Today's open
$550.69
Day's range
$545.76 - $553.54
52 week range
$365.21 - $562.24
show more
CEO
Kevin J. McNamara
Employees
15811
Headquarters
Cincinnati, OH
Exchange
New York Stock Exchange
Shares outstanding
13014915
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Chemed: 3 Key Takeaways for Long-Term Investors
Chemed spent $96 million reacquiring Roto-Rooter franchise territories during 2026. VITAS Healthcare increased average daily patient census by 9.4%.
The Motley Fool • 15 hours ago

Here's Why Chemed (CHE) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Nov 10, 2026

Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript
Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript
Seeking Alpha • Nov 9, 2026

Chemed Corporation Declares Quarterly Dividend of 70 Cents
CINCINNATI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This is equal to the dividend paid in September 2026.
GlobeNewsWire • Nov 6, 2026

Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference
CINCINNATI, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2026 Global Healthcare Conference on Monday, November 9, 2026, at approximately 8:45 a.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida.
GlobeNewsWire • Nov 2, 2026

Why Chemed (CHE) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 2, 2026

What Chemed (CHE) Said on Its Q3 Earnings Call
Chemed NYSE: CHE reported higher third-quarter revenue and adjusted earnings as growth at its VITAS hospice business offset margin pressure at Roto-Rooter from customer-acquisition and fuel costs.
MarketBeat • Oct 29, 2026

Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript
Chemed Corporation ( CHE ) Q3 2026 Earnings Call October 28, 2026 10:00 AM EDT Company Participants Holley Schmidt - Vice President & Assistant Controller Kevin McNamara - CEO, President & Director Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Joel Wherley - Executive VP and President & CEO of VITAS Healthcare Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Albert Rice - UBS Investment Bank, Research Division Presentation Operator Good day, ladies and gentlemen, and thank you for standing by, and welcome to the Chemed Corporation Third Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Seeking Alpha • Oct 28, 2026

Chemed Reports Third-Quarter 2026 Results
CINCINNATI, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2026, versus the comparable prior-year period. Results for Quarter Ended September 30, 2026 Consolidated operating results: Revenue increased 10.6% to $690.9 million GAAP Diluted Earnings-per-Share (EPS) of $5.45, an increase of 22.2% Adjusted Diluted EPS of $6.75, an increase of 28.1% VITAS segment operating results: Net Patient Revenue of $457.4 million, an increase of 12.2% Average Daily Census (ADC) of 24,428, an increase of 9.4% Admissions of 18,995, an increase of 7.2% Net Income, excluding certain discrete items, of $70.8 million, an increase of 44.7% Adjusted EBITDA, excluding Medicare Cap, of $92.5 million, an increase of 31.4% Adjusted EBITDA margin, excluding Medicare Cap, of 20.2%, an increase of 318-basis points Roto-Rooter segment operating results: Revenue of $233.5 million, an increase of 7.5% Net Income, excluding certain discrete items, of $33.3 million, a decline of 1.8% Adjusted EBITDA of $48.2 million, a decline of 2.5% Adjusted EBITDA margin of 20.6%, a decline of 213-basis points VITAS VITAS net revenue was $457.4 million in the third quarter of 2026, which is an increase of 12.2% when compared to the prior-year period.
GlobeNewsWire • Oct 27, 2026

Chemed (CHE) Tops Q3 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $6.75 per share, beating the Zacks Consensus Estimate of $6.39 per share. This compares to earnings of $5.27 per share a year ago.
Zacks Investment Research • Oct 27, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Chemed Corp commission-free¹. Build wealth for the long term using automated trading and transfers.